New Zealand markets open in 30 minutes

Pharmaron Beijing Co., Ltd. (3759.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
8.450-0.140 (-1.63%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 32.22B
Enterprise value 35.49B
Trailing P/E 9.42
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.22
Price/book (mrq)1.11
Enterprise value/revenue 2.88
Enterprise value/EBITDA 17.51

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-48.58%
S&P500 52-week change 322.55%
52-week high 323.400
52-week low 38.250
50-day moving average 39.759
200-day moving average 313.351

Share statistics

Avg vol (3-month) 34.68M
Avg vol (10-day) 32.74M
Shares outstanding 5301.54M
Implied shares outstanding 63.81B
Float 81.14B
% held by insiders 15.12%
% held by institutions 134.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.22
Forward annual dividend yield 42.60%
Trailing annual dividend rate 30.20
Trailing annual dividend yield 32.33%
5-year average dividend yield 4N/A
Payout ratio 435.90%
Dividend date 3N/A
Ex-dividend date 427 Jun 2024
Last split factor 215:10
Last split date 318 Jul 2023

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.92%
Operating margin (ttm)10.81%

Management effectiveness

Return on assets (ttm)4.19%
Return on equity (ttm)11.75%

Income statement

Revenue (ttm)11.48B
Revenue per share (ttm)6.48
Quarterly revenue growth (yoy)-2.00%
Gross profit (ttm)N/A
EBITDA 2.32B
Net income avi to common (ttm)1.48B
Diluted EPS (ttm)0.900
Quarterly earnings growth (yoy)-33.80%

Balance sheet

Total cash (mrq)5.35B
Total cash per share (mrq)2.99
Total debt (mrq)8.25B
Total debt/equity (mrq)61.79%
Current ratio (mrq)2.52
Book value per share (mrq)7.10

Cash flow statement

Operating cash flow (ttm)2.97B
Levered free cash flow (ttm)-741.28M